Locally advanced breast cancer
Item
locally advance breast cancer
boolean
C3495949 (UMLS CUI [1])
Informed Consent
Item
subjects must give appropriate written informed consent prior to participation in the study;
boolean
C0021430 (UMLS CUI [1])
Compliance behavior Safety procedure
Item
subjects must be able and willing to comply with the safety procedures during the scanning period;
boolean
C1321605 (UMLS CUI [1,1])
C1269689 (UMLS CUI [1,2])
Gender | Age
Item
subjects must be women of between 20 and 80 years of age, inclusive, on the day the informed consent form is signed;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Therapeutic radiology procedure Neoadjuvant Locally advanced breast cancer | Chemotherapy Neoadjuvant Locally advanced breast cancer
Item
subjects must be women who will be receiving neoadjuvant radiation therapy and/or chemotherapy for locally-advanced breast cancer.
boolean
C0079399 (UMLS CUI [1])
C1522449 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C3495949 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3,1])
C0600558 (UMLS CUI [3,2])
C3495949 (UMLS CUI [3,3])
Childbearing Potential Contraceptive methods | Female Sterilization | Postmenopausal state | Amenorrhea Duration
Item
subjects of childbearing potential must be using an acceptable method of birth control. subjects not of childbearing potential are defined as either surgically sterile or post-menopausal. post-menopausal women are defined as those women with a documented menstruation cessation for 12 consecutive months prior to signing the informed consent form
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0015787 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0002453 (UMLS CUI [4,1])
C0449238 (UMLS CUI [4,2])
Abnormality Involvement with Breast | Traumatic injury Involvement with Breast | Medical procedure Involvement with Breast | Operation on breast | Silicone implant | Saline breast implant | Lesion Involved Excluded
Item
subjects with a past medical history of abnormalities, significant injury, or medical or surgical procedures (e.g.,silicone/saline implants) involving either breast, exclusive of the lesion at issue;
boolean
C1704258 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C3263723 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C0006141 (UMLS CUI [2,3])
C0199171 (UMLS CUI [3,1])
C1314939 (UMLS CUI [3,2])
C0006141 (UMLS CUI [3,3])
C3714726 (UMLS CUI [4])
C1289793 (UMLS CUI [5])
C0741712 (UMLS CUI [6])
C0221198 (UMLS CUI [7,1])
C1314939 (UMLS CUI [7,2])
C2828389 (UMLS CUI [7,3])
Skin Abnormalities Involvement with Breast | Tattoo | Sore Open | Skin lesion
Item
subjects with any dermatologic abnormalities (including tattoos, open sores, or breached skin) involving either breast;
boolean
C0037268 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C1366940 (UMLS CUI [2])
C1442877 (UMLS CUI [3,1])
C0175566 (UMLS CUI [3,2])
C0037284 (UMLS CUI [4])
Connective Tissue Diseases
Item
subjects with a current or past medical history of connective tissue disease;
boolean
C0009782 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
subjects who are pregnant or lactating;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Implanted Medical Device Electronic | Artificial cardiac pacemaker | Defibrillators | Stimulators, Neurological
Item
subjects with an implanted electronic device such as a cardiac pacemaker, defibrillator, or neurological stimulator;
boolean
C2828363 (UMLS CUI [1,1])
C0013850 (UMLS CUI [1,2])
C0030163 (UMLS CUI [2])
C0180307 (UMLS CUI [3])
C0183597 (UMLS CUI [4])
Anxiety Associated with Evaluation Diagnostic
Item
subjects with a history or expectation of significant anxiety associated with undergoing diagnostic evaluations;
boolean
C0003467 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C1261322 (UMLS CUI [1,3])
C0348026 (UMLS CUI [1,4])
Musculoskeletal Disease
Item
subjects with a history of musculoskeletal disease which may predispose them to discomfort during the scanning period;
boolean
C0026857 (UMLS CUI [1])
Hypersensitivity Purified water | Hypersensitivity Soybean Oil | Hypersensitivity Sucrose | Hypersensitivity Polysorbate 80 | Hypersensitivity Oleic Acid | Hypersensitivity EDTA | Hypersensitivity Benzalkonium Chloride | Hypersensitivity Caramel Color | Hypersensitivity Butylated Hydroxyanisole | Hypersensitivity Sodium Hydroxide
Item
subjects with a known sensitivity to purified water, soybean oil, sucrose, polysorbate 80, oleic acid, edta, benzalkonium chloride, fd&c caramel color, butylated hydroxyanisole, and/or sodium hydroxide;
boolean
C0020517 (UMLS CUI [1,1])
C0991883 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0037732 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0038636 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0032601 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0028928 (UMLS CUI [5,2])
C0020517 (UMLS CUI [6,1])
C0013618 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C0005026 (UMLS CUI [7,2])
C0020517 (UMLS CUI [8,1])
C0108509 (UMLS CUI [8,2])
C0020517 (UMLS CUI [9,1])
C0006506 (UMLS CUI [9,2])
C0020517 (UMLS CUI [10,1])
C0037517 (UMLS CUI [10,2])
Hypersensitivity Infrared Radiation Level low
Item
subjects with a known sensitivity to low-power infrared radiation (e.g., as a result of a dermatologic condition); and
boolean
C0020517 (UMLS CUI [1,1])
C0021431 (UMLS CUI [1,2])
C0441889 (UMLS CUI [1,3])
C0205251 (UMLS CUI [1,4])
Study Subject Participation Status Inappropriate
Item
subjects, who, in the opinion of the investigator or clinical research coordinator, may not otherwise be appropriate for inclusion into the study.
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])